You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
In Vitro Equivalence Testing of Amlodipine Besylate Tablets under BCS-Based Biowaiver Conditions
- In: Posters
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- Poster code: IPS-P-18
- By: QUIZON, Paul Marvin (University of the Philippines Manila, College of Pharmacy, Manila, Philippines)
- Abstract:
..
I. Background:
At present, bioequivalence testing involving pharmacokinetic endpoints is the generally accepted method of demonstrating therapeutic equivalence and drug product interchangeability. However, the disadvantages associated with in vivo studies brought about the development of in vitro equivalence testing and biowaivers based on the The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026